MEKANISME REGULASI SEL
DOI:
https://doi.org/10.59003/nhj.v5i9.1928Keywords:
Cell cycle, Cyclins, CDKs, Molecular regulation, cancer.Abstract
The cell cycle is a fundamental biological process that regulates growth, DNA replication, and cell division in a coordinated manner. Cell cycle regulation plays a crucial role in maintaining tissue homeostasis, genome stability, and preventing uncontrolled cell proliferation. Disruptions in cell cycle regulatory mechanisms are known to contribute to various diseases, particularly cancer, through the loss of checkpoint control and excessive activation of proliferation pathways. Therefore, studying cell cycle regulatory mechanisms is crucial to strengthen biological understanding and its clinical implications in the development of molecularly targeted therapies. This study employed a literature review method with a descriptive-analytical approach. Data were obtained from international scientific articles published in reputable databases and analyzed qualitatively to examine the molecular mechanisms of cell cycle regulation, the role of cyclin-CDK complexes, checkpoint systems, CDK inhibitors, and their association with physiological and pathological conditions. The results indicate that cell cycle regulation is primarily controlled by the activity of cyclin-CDK complexes, which operate in a phase-specific and coordinated manner. Checkpoint systems at the G1/S, G2/M transitions, and spindle assembly function as surveillance mechanisms to ensure accurate DNA replication and chromosome division. Regulatory pathways such as Rb-E2F and p53 play a crucial role in arresting the cell cycle upon DNA damage or cellular stress. Furthermore, it has been discovered that the ubiquitin-proteasome-based protein degradation system also plays a role in regulating the stability of cell cycle regulators, thus refining the classical regulatory model that previously focused solely on cyclin-CDK activation. Cell cycle regulation is a highly controlled, dynamic, and integrated biological process, with cyclin-CDK complexes and checkpoint systems playing a central role in determining the continuation of cell proliferation. A comprehensive understanding of these regulatory mechanisms provides a crucial contribution to the development of therapeutic strategies, particularly in the treatment of cancer and other proliferative disorders, through approaches based on cell cycle pathway control.
Downloads
References
Sandy O:, Dini A, Mudmawati S, Rahayu RM, Anggraini SN. PT. Media Akademik Publisher PERKEMBANGAN PENELITIAN SIKLUS SEL DALAM BIDANG BIOLOGI SEL MODERN: SUATU TINJAUAN LITERATUR. JMA). 2025;3(11):3031–5220. doi:10.62281
Glaviano A, Singh SK, Lee EHC, Okina E, Lam HY, Carbone D, et al. Cell cycle dysregulation in cancer. Pharmacol Rev. 2025 Mar;77(2):100030. doi:10.1016/j.pharmr.2024.100030
Nilmani, D’costa M, Bothe A, Das S, Udhaya Kumar S, Gnanasambandan R, et al. CDK regulators—Cell cycle progression or apoptosis—Scenarios in normal cells and cancerous cells. In. 2023. p. 125–77. doi:10.1016/bs.apcsb.2022.11.008
Baek K, Scott DC, Henneberg LT, King MT, Mann M, Schulman BA. Systemwide disassembly and assembly of SCF ubiquitin ligase complexes. Cell. 2023 Apr;186(9):1895-1911.e21. doi:10.1016/j.cell.2023.02.035
Konagaya Y, Rosenthal D, Ratnayeke N, Fan Y, Meyer T. An intermediate Rb–E2F activity state safeguards proliferation commitment. Nature. 2024 Jul 11;631(8020):424–31. doi:10.1038/s41586-024-07554-2
McAinsh AD, Kops GJPL. Principles and dynamics of spindle assembly checkpoint signalling. Nat Rev Mol Cell Biol. 2023 Aug 24;24(8):543–59. doi:10.1038/s41580-023-00593-z
Zhang H, Xu J, Long Y, Maimaitijiang A, Su Z, Li W, et al. Unraveling the Guardian: p53’s Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies. Int J Mol Sci. 2024 Dec 1;25(23):12928. doi:10.3390/ijms252312928
Almalki SG. The pathophysiology of the cell cycle in cancer and treatment strategies using various cell cycle checkpoint inhibitors. Pathol Res Pract. 2023 Nov;251:154854. doi:10.1016/j.prp.2023.154854
Pellarin I, Dall’Acqua A, Favero A, Segatto I, Rossi V, Crestan N, et al. Cyclin-dependent protein kinases and cell cycle regulation in biology and disease. Signal Transduct Target Ther. 2025 Jan 13;10(1):11. doi:10.1038/s41392-024-02080-z
Song G, Liu J, Tang X, Zhong J, Zeng Y, Zhang X, et al. Cell cycle checkpoint revolution: targeted therapies in the fight against malignant tumors. Front Pharmacol. 2024 Oct 11;15. doi:10.3389/fphar.2024.1459057
Peng Y, Liu J, Inuzuka H, Liu J, Wei W. Targeting the cell-cycle machinery for cancer therapy. Trends Cell Biol. 2025 Sep. doi:10.1016/j.tcb.2025.08.008
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Suharni

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
NHJ is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Articles in this journal are Open Access articles published under the Creative Commons CC BY-NC-SA License This license permits use, distribution and reproduction in any medium for non-commercial purposes only, provided the original work and source is properly cited.
Any derivative of the original must be distributed under the same license as the original.



















